期刊文献+

鼻腔免疫与COVID-19疫苗研发进展 被引量:2

Nasal immunization and research progress of the development of COVID-19 vaccine
原文传递
导出
摘要 合适的免疫途径对诱导有效的免疫保护至关重要。与传统肌内注射、皮下注射等有创免疫方式相比,鼻腔免疫具有使用方便、接种者依从性高、引发免疫反应更全面等优势,在新型冠状病毒肺炎(COVID-19)疫情中引起了研发人员的重视。本文扼要介绍了鼻腔免疫的机制及特点,并对以鼻腔为接种途径的COVID-19疫苗及技术平台进行总结分析,为相关研发工作提供参考。 The appropriate immune pathway is the key to induce effective immune protection. Compared with traditional invasive immunization methods such as intramuscular injection and subcutaneous injection, nasal immunization has the advantages of convenient use, high compliance of vaccinators and induction of more comprehensive immune response, thus has attracted the attention of researchers in the epidemic of COVID-19. This paper briefly introduces the mechanism and characteristics of nasal immunization, summarizes the COVID-19 vaccine products and technology platforms regarding nasal immunization, so as to provide reference for related research and development work.
作者 葛华 蒋丽勇 刘术 刁天喜 GE Hua;JIANG Li-yong;LIU Shu;DIAO Tian-xi(Institute of Health Service and Transfusion Medicine,Academy of Military Medical Sciences,Academy of Military Sciences,Beijing 100850,China)
出处 《中国新药杂志》 CAS CSCD 北大核心 2022年第9期863-870,共8页 Chinese Journal of New Drugs
关键词 鼻腔免疫 COVID-19疫苗 产品 技术 nasal immunization COVID-19 vaccine products technologies
  • 相关文献

参考文献10

二级参考文献123

  • 1李建国,吴浩,黄志清,陈瑞,尹松梅,李依群,詹俊,江山平,伍卫.干扰素-α治疗严重急性呼吸综合征的临床研究[J].中国综合临床,2005,21(2):109-110. 被引量:6
  • 2Klausner RD,Fauci AS,Corey L,et al.Medicine.The need for a global HIV vaccine enterprise[J].Science,2003,300 (5628):2036-2039.
  • 3Ugwoke MI,Verbeke N,Kinget R.The biopharmaceutical aspects of nasal mucoadhesive drug delivery[J].J Pharm Pharmacol,2001,53 (1):3-21.
  • 4Ugwoke MI,Agu RU,Verbeke N,et al.Nasal mucoadhesive drug delivery:background,applications,trends and future perspectives[J].Adv Drug Del Rev,2005,57 (11):1640-1665.
  • 5Kunkel EJ,Butcher EC.Plasma-cell homing[J].Nat Rev Immunol,2003,3 (10):822-829.
  • 6Morein B,Sundquist B,Hoglund S,et al.ISCOM,a novel structure for antigenic presentation of membrane-proteins from enveloped viruses[J].Nature,1984,308 (5958) 457-460.
  • 7Maraskovsky E,Sjolander S,Drane DP,et al.Ny-eso-1 protein formulated in iscomatrix adjuvant is a potent anticancer vaccine inducing both humoral and CD8 (+) T-cellmediated immunity and protection against ny-eso-1 (+) tumors[J].Clin Cancer Res,2004,10(8):2879-2890.
  • 8Catol H,Nieto A.A mucosal IgA response,but no systemic antibody response,is evoked by intranasal immunisation of dogs with echinococcus granulosus surface antigens ISCOMs[J].Vet Immunol Immunopathol,1998,65 (1):29-41.
  • 9Koopman G,Bogers WM,van Gils M,et al.Comparison of intranasal with targeted lymph node immunization using PR8-Flu ISCOM adjuvanted HIV antigens in macaques[J].J Med Virol,2007,79 (5):474-482.
  • 10Li F,Michalek SM,Dasanayake AP,et al.Childers,intranasal immunization of humans with streptococcus mutans antigens[J].Oral Microbiol Immunol,2003,18 (5):271-277.

共引文献39

同被引文献8

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部